Good afternoon :)
Place Order
Add to Watchlist

Zydus Wellness Ltd

ZYDUSWELL

Zydus Wellness Ltd

ZYDUSWELL
Consumer StaplesFMCG - Foods
SmallcapWith a market cap of ₹13,351 cr, stock is ranked 462
Moderate RiskStock is 2.09x as volatile as Nifty
2,054.002.11% (-44.25)
2,054.002.11% (-44.25)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Consumer StaplesFMCG - Foods
SmallcapWith a market cap of ₹13,351 cr, stock is ranked 462
Moderate RiskStock is 2.09x as volatile as Nifty

How to use scorecard? Learn more

Consumer StaplesFMCG - Foods
SmallcapWith a market cap of ₹13,351 cr, stock is ranked 462
Moderate RiskStock is 2.09x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
41.832.490.24%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.6710.261.46%

Forecast & Ratings

Detailed Forecast 
83%
Analysts have suggested that investors can buy this stock

from 6 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Zydus Wellness Limited is an integrated consumer company, engaged in the development, production, marketing and distribution of health and wellness products.

Investor Presentation

View older 

Nov 11, 2024

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 21.57%, vs industry avg of 9.59%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 1.04% to 1.76%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 9.55%, vs industry avg of 11.05%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue429.10463.21547.68881.701,777.531,875.612,019.502,259.702,341.702,542.00
Raw Materialssubtract120.0795.89112.35240.72694.16885.99979.571,214.501,147.902,169.90
Power & Fuel Costsubtract3.434.025.159.6021.6225.0331.4243.3041.50
Employee Costsubtract39.3745.4653.6185.60156.01163.83163.56167.30193.40
Selling & Administrative Expensessubtract124.05128.59144.12232.36419.51422.44423.00481.10557.90
Operating & Other expensessubtract18.4357.5472.13100.19198.66157.1566.8021.5093.10
Depreciation/Amortizationsubtract6.817.168.8812.5126.3925.1623.6225.0023.8021.80
Interest & Other Itemssubtract0.140.551.7030.09139.9183.8025.5116.1024.0016.90
Taxes & Other Itemssubtract13.5415.0215.841.49-20.45-6.52-2.85-19.50-6.8014.20
EPS26.4327.8934.2734.9724.5819.5848.5448.7841.9450.16
DPS6.506.508.005.005.005.005.005.005.005.00
Payout ratio0.250.230.230.140.200.260.100.100.120.10

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

Sep 10PDF
FY 2022

Annual report

PDF

Investor Presentation

May 17PDF
May 17PDF
Feb 2PDF
FY 2023

Annual report

PDF

Investor Presentation

May 17PDF
Feb 2PDF
Nov 10PDF
Jul 29PDF
FY 2024

Annual report

PDF

Investor Presentation

Aug 3PDF
FY 2025

Annual Report Pending

Investor Presentation

Nov 11PDF
 

Peers & Comparison

Comparing 3 stocks from 
Consumer StaplesFMCG - Foods

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Zydus Wellness Ltd50.022.490.24%
Nestle India Ltd55.3565.161.43%
Britannia Industries Ltd54.6129.461.51%
Adani Wilmar Ltd274.164.88—

Price Comparison

Compare ZYDUSWELL with any stock or ETF
Compare ZYDUSWELL with any stock or ETF
ZYDUSWELL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.62%11.97%8.40%3.37%6.66%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep3.23%3.42%3.25%3.26%3.29%3.37%

Mutual Funds Holding Trend

Increased Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 3.59%

Top 5 Mutual Funds holding Zydus Wellness Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Nippon India Small Cap Fund - Growth - Direct Plan

Growth
3.8601%0.84%-0.04%19/232 (-2)
Quant Small Cap Fund - Growth - Direct Plan

Growth
2.2411%1.14%0.87%59/94 (+17)
SBI Small Cap Fund - Growth - Direct Plan

Growth
1.2423%0.50%-0.52%57/63 (-14)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Zydus Wellness Ltd

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

ZYDUSWELL has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.24%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.38 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 19, 2024

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Jul 19, 2024

Cash Dividend

Ex DateEx DateJul 21, 2023

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Jul 21, 2023

Cash Dividend

Ex DateEx DateJul 14, 2022

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Jul 14, 2022

Cash Dividend

Ex DateEx DateJul 14, 2021

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Jul 14, 2021

Cash Dividend

Ex DateEx DateMar 19, 2020

Interim
Interim | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Mar 19, 2020

News & Opinions
Corporate
Zydus Wellness acquires 98.14% stake in Naturell (India)

Zydus Wellness has acquired 98.14% equity stake in Naturell (India). Powered by Capital Market - Live

5 days agoCapital Market - Live
Earnings
Zydus Wellness consolidated net profit rises 254.24% in the September 2024 quarter

Net profit of Zydus Wellness rose 254.24% to Rs 20.90 crore in the quarter ended September 2024 as against Rs 5.90 crore during the previous quarter ended September 2023. Sales rose 12.06% to Rs 490.70 crore in the quarter ended September 2024 as against Rs 437.90 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales490.70437.90 12 OPM %3.993.84 - PBDT22.7014.40 58 PBT17.808.60 107 NP20.905.90 254 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Zydus Wellness to convene board meeting

Zydus Wellness will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Zydus Wellness director resigns

Zydus Wellness announced the resignation of Ashish P. Bhargava, Nominee Director (representing Threpsi Care LLP) on 30 September 2024. Powered by Capital Market - Live

2 months agoCapital Market - Live

Zydus Wellness Q1 profit surges 33.78% amidst strong brand performance

4 months agoBusiness Standard

Zydus Wellness consolidated net profit rises 33.79% in the June 2024 quarter

4 months agoBusiness Standard
Earnings
Zydus Wellness consolidated net profit rises 33.79% in the June 2024 quarter

Net profit of Zydus Wellness rose 33.79% to Rs 147.70 crore in the quarter ended June 2024 as against Rs 110.40 crore during the previous quarter ended June 2023. Sales rose 20.01% to Rs 839.10 crore in the quarter ended June 2024 as against Rs 699.20 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales839.10699.20 20 OPM %18.5116.66 - PBDT156.70113.80 38 PBT151.60107.60 41 NP147.70110.40 34 Powered by Capital Market - Live

4 months agoCapital Market - Live

Zydus Wellness expands its Complan portfolio with new launch

4 months agoThe Hindu Businessline

Technical Breakout Stocks: Alembic Pharma, Dr Lal PathLabs and Zydus Wellness hit 52-week highs; what should traders do? - Market Roundup

4 months agoEconomic Times

Zydus Wellness stock jumps 5%; hits 2-year high on hopes of demand recovery

4 months agoBusiness Standard